Metastasis is the leading cause of death in breast cancer patients and an appropriate detection of metastasis can provide better prognosis and quality treatments. Microwaves can reveal the unique electromagnetic properties of materials, and this study aims to unleash the electromagnetic properties of breast cancer cells, especially, metastasized cancer cells in the lymph nodes, using broad-band microwaves in attempts to detect metastases. To distinguish the cancer-specific patterns of cancer tissues, three primary microwave parameters were assessed, i.e., permittivity in mid-band frequency (3-5 GHz), conductivity in high-band frequencies (25-30 GHz) and slope changes of permittivity at high-band frequencies (15-30 GHz). An additional parameter, Cancer Metastasis Index (CMI), was developed to effectively represent all parameters. Broadband microwave scanning can reveal cancer specific electromagnetic behaviors in all three parameters, and these were reliably reflected by CMI. CMI effectively magnified the difference of the electromagnetic properties between normal nodal tissues and cancer tissues. immunohistochemistries were performed to verify the origin of electromagnetic changes represented by CMI values.
To overcome the limits of conventional microwave ablation, a new frequency spectrum above 6 GHz has been explored for low-power and low collateral damage ablation procedure. A planar coaxial probe-based applicator, suitable for easy insertion into the human body, was developed for our study to cover a wideband frequency up to 30 GHz. Thermal ablations with small input power (1-3 W) at various microwave frequencies were performed on nude mice xenografted with human breast cancer. Comparative study of ablation efficiencies revealed that 18-GHz microwave results in the largest difference in the temperature rise between cancer and normal tissues as well as the highest ablation efficiency, reaching 20 times that of 2 GHz. Thermal profile study on the composite region of cancer and fat also showed significantly reduced collateral damage using 18 GHz. Application of low-power (1 W) 18-GHz microwave on the nude mice xenografted with human breast cancer cells resulted in recurrence-free treatment. The proposed microwave ablation method can be a very effective process to treat small-sized tumor with minimized invasiveness and collateral damages.Breast cancer is a major threat to women's health psychologically as well as physically. 1 Despite the high potential of fatality, most women show reluctance for large-scale breast removal due to cosmetic concerns, which brings about the need for local surgical control. For this reason, minimally invasive techniques to achieve better local surgical control have collected extensive attention as a possible first-line treatment in lieu of conservative breast surgery procedures such as lumpectomy. 2,3 Among several alternative methods, microwave ablation entails many benefits in comparison with the others such as laser ablation, cryoablation and ethanol ablation. [4][5][6][7][8] Microwave ablation method is much safer and easily manageable 9 and can, in principle, offer material-specific responsiveness, where tissues with high water content such as cancer are preferentially heated and damaged. 10,11 This characteristic of microwaves makes microwave ablation well suited for local treatment of early stage of breast cancer. So far, the frequencies used in the existing microwave ablation systems have been limited to the low-frequency spectrum such as 915 MHz or 2.4 GHz. Because of the inherent low radiation efficiency, very high microwave input power of several tens of Watts is required at these frequencies, thus greatly increasing the cost and size of the equipment. 12 Moreover, because of the self-heating of the applicator by the excessive microwave power, additional means for cooling the applicator are required to avoid the damage of healthy tissues near the passage of the applicator. 13 Besides, the conventional low-frequency spectrum ablation has poor material selectivity when compared to the alternative high-frequency spectrum proposed in our work.To overcome the limitations of the existing microwave ablation methods, we have investigated the properties of microwaves up to 30 GHz wit...
A developing method of cancer detection is to use electromagnetic waves to compare the dielectric properties of normal and cancerous tissue. Because most of the previous studies consisted of dielectric measurements taken ex-vivo, this study investigated the advantages of in-vivo measurements, obtained using the newly developed insertion-type planar probe, through the measurements of cancer (MDA MB 231), which was cultivated and implanted into the mammary fat pad of nude mice. Reflection coefficients were obtained in the broadband frequency range from 0.5 to 30 GHz, from which broadband complex permittivity data was extracted. Complex permittivity, in addition to other parameters such as conductivity and characteristic frequency, were used to make comparisons between cancerous tissue, normal muscle tissue and fat tissue, as well as comparisons between in-vivo and ex-vivo measurements. This study investigated the suitability of in-vivo cancer detection using microwaves with the newly developed insertion-type planar probe. Results showed that both sensitivity and specificity of the current method was 97%. In addition, predictive values were 99% for the positive and 94% for the negative, thus greatly enhancing the practicality of this method. In conclusion, it was demonstrated that in-vivo measurements are highly beneficial in studying the potential of microwaves as a diagnostic tool of breast cancer, especially in combination with the newly developed insertion-type planar probe.
We implemented a micromachined probe for the measurement of biological properties using MEMS technology, and experimentally showed the suitability of the micromachined probe in biological applications. The micromachined probe was fabricated on a silicon substrate, and to remove wave transmission through the silicon substrate, we etched the silicon substrate from beneath a lower ground and made the etched silicon surface conducting by using thermal evaporation of Cr/Au and a coating of conductive epoxy. The micromachined probe consists of a CPW and strip line between benzo cyclo butene (BCB) layers, which is known to be a material with high resistivity, low loss tangent, and low permittivity at high frequency. We measured the permittivity of a number of well-known liquids—0.5%, 0.9% and 1.3% saline, acetone, ethanol, and muscle and fat of pork—as biological samples using the micromachined probe after liquid calibration. The measured permittivity of 0.9% saline agreed well with the expected value of the Cole–Cole equation. In this paper, we first demonstrate that the micromachined probe can provide broadband measurement of measurable solid materials, such as biological samples, and also of well-known liquids at microwave frequencies. The size of the micromachined probe is 2000 µm (width) × 580 µm (thickness) × 30 000 µm (length), and the aperture size of the micromachined probe is only 650 µm × 70 µm. Therefore, we can extract the biological information from very small biological tissues and reduce radiation effects. Thus we show the feasibility of low-cost, small and portable permittivity measurement systems using a micromachined open-ended coaxial RF MEMS probe.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.